VENTYX BIOSCIENCES
Ventyx Biosciences is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Ventyxโs clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1 peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions.
VENTYX BIOSCIENCES
Industry:
Biopharma Biotechnology
Founded:
2018-01-01
Address:
Encinitas, California, United States
Country:
United States
Website Url:
http://www.ventyxbio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
165 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Selecta Biosciences
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
RTW Investments LLC
RTW Investments LLC investment in Series B - Ventyx Biosciences
Third Point
Third Point investment in Series B - Ventyx Biosciences
Farallon Capital Management
Farallon Capital Management investment in Series B - Ventyx Biosciences
venBio Partners
venBio Partners investment in Series B - Ventyx Biosciences
Wellington Management
Wellington Management investment in Series B - Ventyx Biosciences
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Ventyx Biosciences
OrbiMed
OrbiMed investment in Series B - Ventyx Biosciences
Qiming Venture Partners USA
Qiming Venture Partners USA investment in Series B - Ventyx Biosciences
Surveyor Capital
Surveyor Capital investment in Series B - Ventyx Biosciences
Logos Capital
Logos Capital investment in Series B - Ventyx Biosciences
Key Employee Changes
Date | New article |
---|---|
2022-05-09 | Ventyx Biosciences Announces Appointment of William Sandborn, MD, as President and Chief Medical Officer |
Official Site Inspections
http://www.ventyxbio.com Semrush global rank: 2.22 M Semrush visits lastest month: 8.76 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago